IFNG and head and neck squamous cell carcinoma: Current studies of HNSCC immunotherapy showed IFN-γ-related gene difference was the mainstream change (11, 48), while TME classification did not show a significant difference in IFN-γ expression between the active immune class and exhausted immune class (45).